The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
The Effects of Amiodarone on the Thyroid*
Abstract
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T(4) and rT(3), and a decrease in serum T(3), concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T(3) from T(4) and a decrease in the clearance of rT(3). In 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AIH is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T(4) replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Perchlorate and the Thyroid Gland
Wolff, J. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01350-4 · Cited by 588
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370
Self-citationPhosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis
Tarui, S., Giichi, O., Ikura, Y., Tanaka, T., Suda, M., & Nishikawa, M. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90156-7 · Cited by 369
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
Cited by
Items 101–200 of 615
Iodine mediated mechanisms and thyroid carcinoma
Liu, X. H., Chen, G. Y., Vlantis, A. C., & van Hasselt, C. A. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408360903306384 · Cited by 52
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy
Bogazzi, F., Aghini-Lombardi, F., Cosci, C., Lupi, I., Santini, F., Tanda, M. L., Miccoli, P., Basolo, F., Pinchera, A., Bartalena, L., et al. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343984 · Cited by 51
Self-citationJabrocka‐Hybel, A., Bednarczuk, T., Bartalena, L., Pach, D., Ruchała, M., Kamiński, G., Kostecka-Matyja, M., & Hubalewska–Dydejczyk, A. (2015) · Endokrynologia Polska · doi:10.5603/ep.2015.0025 · Cited by 50
Self-citationBogazzi, F., Dell’Unto, E., Tanda, M. L., Tomisti, L., Cosci, C., Aghini-Lombardi, F., Sardella, C., Pinchera, A., Bartalena, L., & Martino, E. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344178 · Cited by 49
Self-citationBogazzi, F., Raggi, F., Ultimieri, F., Russo, D., Campomori, A., McKinney, J. D., Pinchera, A., Bartalena, L., & Martino, E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03348194 · Cited by 49
Self-citationHashimoto’s thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism
Takasu, N., & Noh, J. Y. (2008) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.2.221 · Cited by 46
Effect of dietary soy on serum thyroid hormone concentrations in healthy adult cats
White, H. L., Freeman, L. M., Mahony, O. M., Graham, P. A., Qin, H., & Court, M. H. (2004) · American Journal of Veterinary Research · doi:10.2460/ajvr.2004.65.586 · Cited by 46
Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
Cao, Y., Blount, B. C., Valentín-Blasini, L., BERNBAUM, J. C., Phillips, T. M., & Rogan, W. J. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901736 · Cited by 45
Amiodarone‐induced thyroid dysfunction associated with cumulative dose
Bouvy, M. L., Heerdink, E. R., Hoes, A. W., & Leufkens, H. G. M. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.735 · Cited by 45
Cardiovascular risk in elderly hypothyroid patients
Mariotti, S., & Cambuli, V. M. (2007) · Thyroid · doi:10.1089/thy.2007.0130 · Cited by 44
“Since in the elderly the use of drugs and medicaments containing iodine (amio-darone, radiographic contrast agent, and antiseptic solutions) is more frequent (8), the excess of iodine intake is an important cause of hypothyroidism in this class of age (8,10).”
Takawale, A. R., Aguilar, M., Bouchrit, Y., & Hiram, R. (2022) · Cells · doi:10.3390/cells11244047 · Cited by 44
Mariani, G., Tonacchera, M., Grosso, M., Fiore, E., Falcetta, P., Montanelli, L., Bagattini, B., Vitti, P., & Strausś, H. W. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.251504 · Cited by 44
Selenium and Iodine in Autoimmune Thyroiditis
Guastamacchia, E., Giagulli, V. A., Licchelli, B., & Triggiani, V. (2015) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530315666150619094242 · Cited by 44
Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience
Kotwal, A., Clark, J. E., Lyden, M. L., McKenzie, T. J., Thompson, G. B., & Stan, M. N. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00259 · Cited by 43
A Stepwise Approach to the Treatment of Amiodarone-Induced Thyrotoxicosis
Erdoğan, M. F., Güleç, S., Tutar, E., Başkal, N., & Erdoğan, G. (2003) · Thyroid · doi:10.1089/105072503321319521 · Cited by 42
Fouad, G. I., & Mousa, M. R. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04173-7 · Cited by 42
Stan, M. N., Ammash, N. M., Warnes, C. A., BRENNAN, M. D., Thapa, P. B., Nannenga, M. R., & Bahn, R. S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.02.015 · Cited by 42
Mandel, S. J., Larsen, P. R., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00012-2 · Cited by 41
Amiodarone - waxed and waned and waxed again
Doggrell, S. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.11.1877 · Cited by 41
Alzahrani, A. S., Ceresini, G., & Aldasouqi, S. A. (2012) · Endocrine Practice · doi:10.4158/ep11170.ra · Cited by 39
Determinants of thyroid autoantibody production in Hashimoto’s thyroiditis
Zaletel, K. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.2.217 · Cited by 39
Davies, T. F., Laurberg, P., & Bahn, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00012-5 · Cited by 39
Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010)
Pedro, B., López‐Alvarez, J., Fonfara, S., Stephenson, H., & Dukes‐McEwan, J. (2011) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.2011.01142.x · Cited by 38
Endocrine system dysfunction and chronic heart failure: a clinical perspective
Lisco, G., Giagulli, V. A., Iovino, M., Zupo, R., Guastamacchia, E., Pergola, G. D., Iacoviello, M., & Triggiani, V. (2021) · Endocrine · doi:10.1007/s12020-021-02912-w · Cited by 37
Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey
DIEHL, L. A., Romaldini, J. H., Graf, H., Bartalena, L., Martino, E., Albino, C. C., & Wiersinga, W. M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02590.x · Cited by 37
Self-citationManagement of thyroid disorders
Premawardhana, L. D. K. E., & Lazarus, J. H. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.047290 · Cited by 36
Developmental toxic effects of chronic exposure to high doses of iodine in the mouse
Yang, X. F., Xu, J., Hou, X. H., Guo, H. L., Li, H., Yao, P., Liu, L. G., & Sun, X. F. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.05.010 · Cited by 36
Toxicological profile for perchlorates
Diamond, G., & Wilbur, S. B. (2008) · University of Michigan Library Repository · Cited by 36
Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature
Maqdasy, S., Benichou, T., Dallel, S., Roche, B., Desbiez, F., Montanier, N., Batisse‐Lignier, M., & Tauveron, I. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.05.001 · Cited by 36
Risk factors for amiodarone‐induced thyroid dysfunction in Japan
Kinoshita, S., Hayashi, T., Wada, K., Yamato, M., Kuwahara, T., Anzai, T., Fujimoto, M., Hosomi, K., & Takada, M. (2016) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.03.008 · Cited by 35
Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH
Moran, C., Schoenmakers, N. A., Halsall, D. J., Oddy, S., Lyons, G., van den Berg, S. A. A., Gurnell, M., & Chatterjee, K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad681 · Cited by 33
Pasimeni, G., Caroli, F.-X., Spriano, G., Antonini, M., Baldelli, R., & Appetecchia, M. (2008) · Journal of Clinical Apheresis · doi:10.1002/jca.20161 · Cited by 33
Uncommon Causes of Thyrotoxicosis
Mittra, E., Niederkohr, R. D., Rodriguez, C., El-Maghraby, T., & McDougall, I. R. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041202 · Cited by 33
Wong, R., Cheung, W., Stockigt, J. R., & Topliss, D. J. (2003) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2003.00463.x · Cited by 32
Pattison, D. A., Westcott, J., Lichtenstein, M., Toh, H. B., Gunawardana, D. H., Better, N., Forehan, S. P., & Sivaratnam, D. A. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000260 · Cited by 32
Theodoraki, A., & Vanderpump, M. P. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12988 · Cited by 32
Thyroid Ultrasound Part 1: Technique and Diffuse Disease
Sholosh, B., & Borhani, A. A. (2011) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2011.02.002 · Cited by 32
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
Uzan, L., Guignat, L., Meune, C., Mouly, S., Weber, S., Bertagna, X., Bertherat, J., Thomopoulos, P., & Duboc, D. (2006) · Drug Safety · doi:10.2165/00002018-200629030-00006 · Cited by 31
Kubicki, R., Grohmann, J., Kunz, K.-G., Stiller, B., Schwab, K. O., & van der Werf-Grohmann, N. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0032 · Cited by 31
Hoermann, R., Pekker, M. J., Midgley, J. E. M., & Dietrich, J. W. (2023) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231158163 · Cited by 31
Influence of medications on thyroid function in dogs: An update
Bolton, T. A., & Panciera, D. L. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16823 · Cited by 31
Zidan, R. A. (2011) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000395190.66459.04 · Cited by 31
Seigel, S. C., & Hodak, S. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.016 · Cited by 31
Dayem, M. A., Navarro, V., Marsault, R., Darcourt, J., Lindenthal, S., & Pourcher, T. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.015 · Cited by 31
Treatment of amiodarone-associated thyrotoxicosis
Franklyn, J. A., & GAMMAGE, M. D. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0592 · Cited by 31
Prevalence of Amiodarone-Induced Thyrotoxicosis and Associated Risk Factors in Japanese Patients
Uchida, T., Kasai, T., Takagi, A., Sekita, G., Komiya, K., Takeno, K., Shigihara, N., Shimada, K., Miyauchi, K., Fujitani, Y., et al. (2014) · International Journal of Endocrinology · doi:10.1155/2014/534904 · Cited by 31
Can Amiodarone Be Restarted After Amiodarone-Induced Thyrotoxicosis?
Ryan, L. E., Braverman, L. E., Cooper, D. S., Ladenson, P. W., & Kloos, R. T. (2004) · Thyroid · doi:10.1089/105072504322880391 · Cited by 31
Self-citationDrug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations
Tsadok, M. A., Jackevicius, C. A., Rahme, E., Essebag, V., Eisenberg, M. J., Humphries, K. H., Tu, J. V., Behlouli, H., Joo, J., & Pilote, L. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101800 · Cited by 30
Management of amiodarone-induced thyrotoxicosis
Rajeswaran, C., Shelton, R. J., & Gilbey, S. G. (2003) · Swiss Medical Weekly · doi:10.4414/smw.2003.10296 · Cited by 30
Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis
Mohammadi, K., Shafie, D., Vakhshoori, M., Bondariyan, N., Rezvanian, H., & Heidarpour, M. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.01.001 · Cited by 29
You, H.-S., Yoon, J. H., Cho, S. B., Choi, Y.-D., Kim, Y. H., Choi, W., Kang, H., & Choi, S. K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.839441 · Cited by 29
Kurose, K., Saeki, M., Tohkin, M., & Hasegawa, R. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.020 · Cited by 29
The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy
Li, C., Zhou, J., Huang, Z., Pan, X., Leung, W., Chen, L., Zhang, Y., Wang, L., Sima, Y., Gober, H.-J., et al. (2020) · Disease Markers · doi:10.1155/2020/8871951 · Cited by 29
Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism
Hofmann, A., Nawara, C., Ofluoglu, S., Holzmannhofer, J., Strohmer, B., & Pirich, C. (2008) · Wiener klinische Wochenschrift · doi:10.1007/s00508-008-1017-2 · Cited by 29
Endocrine Assessments During Critical Illness
Sakharova, O. V., & Inzucchi, S. E. (2007) · Critical Care Clinics · doi:10.1016/j.ccc.2007.05.007 · Cited by 29
Hyperthyroidism: advantages and disadvantages of medical therapy
Pearce, E. N., & Braverman, L. E. (2004) · Surgical Clinics of North America · doi:10.1016/j.suc.2004.01.007 · Cited by 29
Self-citationDesethylamiodarone antagonizes the effect of thyroid hormone at the molecular level
Bogazzi, F., Bartalena, L., Brogioni, S., Burelli, A., Raggi, F., Ultimieri, F., Cosci, C., Vitale, M., Fenzi, G., & Martino, E. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450059 · Cited by 29
Self-citationClinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)
Halsall, D. J., & Oddy, S. (2021) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563220969150 · Cited by 28
Censi, S., Bodanza, V., Manso, J., Gusella, S., Watutantrige‐Fernando, S., Cavedon, E., Barollo, S., Bertazza, L., Cecchin, D., & Mian, C. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002207 · Cited by 28
The role of therapeutic plasmapheresis in patients with hyperthyroidism
Başer, Ö. Ö., Çetin, Z., Çatak, M., Köseoğlu, D., & Berker, D. S. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102744 · Cited by 28
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?
Tanda, M. L., Bogazzi, F., Martino, E., & Bartalena, L. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0553 · Cited by 28
Self-citationKrysiak, R. G., Gilowska, M., Szkróbka, W., & Okopień, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.11.010 · Cited by 28
[Effect of amiodarone on the thyroid function and safety of the therapy--what's new].
Hen, K., Czarnywojtek, A., Stangierski, A., Warmuz‐Stangierska, I., Zdanowska, J., Florek, E., & Ruchała, M. (2012) · PubMed · Cited by 27
Kim, H., Seo, J., Chung, W., Kim, S., Kim, M., & Zo, J. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.588 · Cited by 27
Tomisti, L., Urbani, C., Rossi, G., Latrofa, F., Sardella, C., Manetti, L., Lupi, I., Marcocci, C., Bartalena, L., Curzio, O., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0426-0 · Cited by 27
Self-citationHennessey, J. V., Garber, J. R., Woeber, K. A., Cobin, R. H., & Klein, I. L. (2016) · Endocrine Practice · doi:10.4158/ep151038.ps · Cited by 27
Plumpton, K., Anderson, B. J., & Beca, J. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1648-4 · Cited by 27
Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
Zosin, I., & Balaş, M. (2012) · PubMed · Cited by 27
Thyroid Hormone Enhances the Formation of Synapses Between Cultured Neurons of Rat Cerebral Cortex
Hosoda, R., Nakayama, K., Kato‐Negishi, M., Kawahara, M., Muramoto, K., & Kuroda, Y. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000005318.53810.de · Cited by 27
Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis
Cappellani, D., Bartalena, L., & Bogazzi, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02168-3 · Cited by 26
Self-citationThyroid function in the critically ill newborn and child
Shih, J. L., & Agus, M. S. D. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832cbc12 · Cited by 26
Albino, C. C., Paz-Filho, G., & Graf, H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03405.x · Cited by 26
Hypothyroidism: Mimicker of Common Complaints
Tews, M. C., Shah, S. M., & Gossain, V. V. (2005) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2005.03.013 · Cited by 26
Hermida, J., JARRY, G., Tcheng, E., Moullart, V., Arlot, S., Rey, J.-L., Delonca, J., & Schvartz, C. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.036 · Cited by 26
Cappellani, D., Papini, P., Certo, A. M. D., Morganti, R., Urbani, C., Manetti, L., Tanda, M. L., Cosentino, G., Marconcini, G., Materazzi, G., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa464 · Cited by 25
Self-citationMacedo, T. A. A., Chammas, M. C., Jorge, P. T., Souza, L. P., Farage, L., Watanabe, T., Santos, V. A., & Cerri, G. G. (2007) · Acta Radiologica · doi:10.1080/02841850701280791 · Cited by 24
Human Exposure to Iodine from the Consumption of Edible Seaweeds
González, A., Paz, S., Rubio, C., Gutiérrez, Á. J., & Hardisson, A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-019-01996-w · Cited by 23
Matsubara, K., Sanoh, S., Ohta, S., Kitamura, S., Sugihara, K., & Fujimoto, N. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.10.004 · Cited by 23
Hermida, J., Tcheng, E., JARRY, G., Moullart, V., Arlot, S., Rey, J.-L., Delonca, J., & Schvartz, C. (2004) · EP Europace · doi:10.1016/j.eupc.2003.11.002 · Cited by 23
Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
Kf, L., Km, L., & Fung, T. (2010) · PubMed · Cited by 23
Sato, K., Shiga, T., Matsuda, N., Onoda, N., Takano, K., Hagiwara, N., & Kasanuki, H. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-027 · Cited by 23
Over-the-Counter-Drug-Induced Thyroid Disorders
Hoang, T. D., Mai, V. Q., Clyed, P. W., & Shakir, M. K. M. (2013) · Endocrine Practice · doi:10.4158/ep12298.or · Cited by 22
Tomisti, L., Re, M. D., Bartalena, L., Tanda, M. L., Pucci, A., Pambianco, F., Pambianco, A., Braverman, L. E., Martino, E., & Bogazzi, F. (2013) · Endocrine Practice · doi:10.4158/ep13093.ra · Cited by 22
Self-citationClinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)
Troshina, E. A., Panfilova, E. A., Mikhina, M. S., Kim, I. V., Семеновна, С. Е., Glibka, A. A., Shifman, B. M., Александровна, Л. А., Шеремета, М. С., Degtyarev, M. V., et al. (2021) · Problems of Endocrinology · doi:10.14341/probl12747 · Cited by 22
Atrial Fibrillation due to Late Amiodarone-Induced Thyrotoxicosis
Kurt, İ. H., Yigit, T., & Karademir, B. M. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828080-00008 · Cited by 22
Calvi, L. M., & Daniels, G. H. (2011) · Thyroid · doi:10.1089/thy.2010.0300 · Cited by 22
Influence of soil type and extraction conditions on perchlorate analysis by ion chromatography
MacMillan, D. K., Dalton, S. R., Bednar, A. J., Waisner, S. A., & Arora, P. N. (2006) · Chemosphere · doi:10.1016/j.chemosphere.2006.09.040 · Cited by 22
Radioactive Iodine in the Treatment of Type-2 Amiodarone-Induced Thyrotoxicosis
Gürsoy, A., Tütüncü, N. B., Anıl, C., Nar, A., Demirağ, N. G., & Gençoğlu, E. A. (2008) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31348-1 · Cited by 22
Amiodarone-Induced Thyrotoxicosis Late After Amiodarone Withdrawal
Yagishita, A., Hachiya, H., Kawabata, M., Nakamura, T., Sugiyama, K., Tanaka, Y., Sasano, T., Isobe, M., & Hirao, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0220 · Cited by 22
Amiodarone-Induced Thyroid Dysfunction
Porsche, R., & Brenner, Z. R. (2006) · Critical Care Nurse · doi:10.4037/ccn2006.26.3.34 · Cited by 22
Kaur, N., Devi, M., Verma, Y., Grewal, P., Bhardwaj, P., Ahlawat, N., & Jangid, N. K. (2019) · SN Applied Sciences · doi:10.1007/s42452-019-1007-1 · Cited by 21
Tedelind, S., Larsson, F., Johanson, C., van Beeren, H. C., Wiersinga, W. M., Nyström, E., & Nilsson, M. (2006) · Endocrinology · doi:10.1210/en.2005-1246 · Cited by 21
Li, R., He, T., Xing, Z., Mi, L., Su, A., & Wu, W. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103783 · Cited by 20
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Åkesson, A., Bampidis, V., Bignami, M., Bodin, L., Degen, G. H., Hernández, A. F., Hofer, T. P., Högstrand, C., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9393 · Cited by 21
Austin, P. C., Park‐Wyllie, L. Y., & Juurlink, D. N. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3607 · Cited by 20
Low dose amiodarone reduces tumor growth and angiogenesis
Steinberg, E., Fluksman, A., Zemmour, C., Tischenko, K., Karsch-Bluman, A., Brill‐Karniely, Y., Birsner, A. E., D’Amato, R. J., & Benny, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-75142-1 · Cited by 20
Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases
Czarnywojtek, A., Płazińska, M. T., Zgorzalewicz-Stachowiak, M., Woliński, K., Stangierski, A., Miechowicz, I., Waligórska‐Stachura, J., Gut, P., Królicki, L., Zioncheck, M., et al. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s96606 · Cited by 20
Tonnelier, A., de Filette, J. M. K., Becker, A. D., Deweer, S., & Velkeniers, B. (2017) · European Thyroid Journal · doi:10.1159/000453578 · Cited by 19
The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients
Barrett, B., Hawkes, C. P., Isaza, A. R., & Bauer, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00990 · Cited by 19
Metadata
- Authors
- Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 240-254
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117317136
- Cited by
- 551
- References
- 154
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.